Literature DB >> 3745353

The diagnosis of muscular dystrophy in patients referred for language delay.

L C Kaplan, P Osborne, E Elias.   

Abstract

The diagnosis of muscular dystrophy is usually made on the basis of gait difficulties or a history of late achievement of normal motor milestones. Other well-described delays, notably in the area of expressive language skills, can provide additional clues to this diagnosis. We present three patients referred to The Developmental Evaluation Clinic because of problems with expressive language observed in school, who ultimately were found to have muscular dystrophy. They are presented to underscore the association of expressive language delay in patients with muscular dystrophy, and to stress the importance of a thorough motor evaluation in children with speech problems.

Entities:  

Mesh:

Year:  1986        PMID: 3745353     DOI: 10.1111/j.1469-7610.1986.tb00641.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  6 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

2.  Poor facial affect recognition among boys with duchenne muscular dystrophy.

Authors:  V J Hinton; R J Fee; D C De Vivo; E Goldstein
Journal:  J Autism Dev Disord       Date:  2006-12-20

3.  Early diagnosis and secondary prevention of Duchenne muscular dystrophy.

Authors:  R A Smith; J R Sibert; S J Wallace; P S Harper
Journal:  Arch Dis Child       Date:  1989-06       Impact factor: 3.791

4.  Delayed developmental language milestones in children with Duchenne's muscular dystrophy.

Authors:  Shana E Cyrulnik; Robert J Fee; Darryl C De Vivo; Edward Goldstein; Veronica J Hinton
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

5.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

6.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.